APGE
Apogee Therapeutics, Inc. Common Stock
NASDAQ: APGE · HEALTHCARE · BIOTECHNOLOGY
$82.03
-3.91% today
Updated 2026-04-29
Market cap
$6.39B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.22
Dividend yield
—
52W range
$34 – $95
Volume
0.9M
Apogee Therapeutics, Inc. Common Stock (APGE) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Operating cash flow | $-16.43M | $-74.76M | $-171.17M | $-227.45M |
| Capital expenditures | $0.00 | $167000.00 | $1.15M | $5.15M |
| Depreciation | — | — | — | — |
| Stock-based comp | $2.14M | $6.10M | $23.33M | $46.28M |
| Free cash flow | $-16.43M | $-74.93M | $-172.33M | $-232.60M |
| Investing cash flow | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Share repurchases | — | — | — | — |
| Debt repayment | — | — | — | — |
| Net change in cash | — | — | — | — |